Michael J. Gitlin

The Psychotherapist's Guide to Psychopharmacology

• Gebundenes Buch

Produktbeschreibung

Michael J. Gitlin's indispensable first edition of The Psychotherapist's Guide to Psychopharmacology has now been updated and revised - this new second edition now reflects major changes that have influenced the clinical arena in the last five years such as the recent release of DSM-IV and the domination of the psychopharmacological field by the selective serotonin reuptake inhibitors, such as fluoxetine (Prozac). The Psychotherapist's Guide to Psychopharmacology, Second Edition also now includes coverage of attention deficit/hyperactivity disorder and contains updated sections on the new antipsychotics for schizophrenia and the increased use of anticonvulsant mood stabilizers for bipolar disorder. The book also includes other significant changes that have influenced the field over the last few years, such as brain imaging studies, research in obsessive compulsive disorder and social phobia, and such prominent topics in women's health as pregnancy, PMS, postpartum disorders, and breast feeding. This revision of an already established guide will again be an essential reference for all nonmedical professionals involved in treating mental and emotional disorders.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Simon & Schuster
• Seitenzahl: 560
• Erscheinungstermin: Mai 1996
• Englisch
• Abmessung: 243mm x 166mm x 43mm
• Gewicht: 934g
• ISBN-13: 9780684827377
• ISBN-10: 0684827379
• Artikelnr.: 22840579

Autorenporträt

Michael J. Gitlin, M.D. is an authority on psychopharmacology who has published numerous articles. He is Clinical Professor of Psychiatry and Director of the Affective Disorders Program and of the General Outpatient Clinic at the UCLA Neuropsychiatric Hospital.

Inhaltsangabe

Contents
List of Illustrations and Tables
Preface
Acknowledgments
SECTION ONE
1. Diagnosis and Treatment: Basic Principles
Descriptive Psychiatry and DSM-IV
Pharmacotherapy and Its Implications for Other Therapies
Evaluating Treatments: The Meaning of the Word Effective
Goals of Pharmacotherapy
Some General Issues in Psychopharmacological Treatment
FDA Approval and PDR Doses
Polypharmacy
Practice Guidelines
Who Should Have a Medication Consultation?
SECTION TWO
2. Biological Basis of Psychopharmacology
Neurotransmission: How Cells Communicate
How Medications Work
Neurotransmitters That Help Regulate Mood and Behavior
Neuroimaging Techniques in Psychiatric Disorders
Biological Hypotheses of the Major Psychiatric Disorders
Mood Disorders
Schizophrenia
Anxiety Disorders
SECTION THREE
3. Mood Disorders
Diagnosis
Major Depression
Subtypes of Major Depressive Disorder
Melancholic Depression
Major Depression with Psychotic Features
Atypical Depression
Seasonal Depression
Postpartum Depression
Bipolar Disorder
Natural History, Epidemiology, and Genetics
Presentations of Mild Mood Disorders
Dysthymia
Cyclothymia
Recurrent Brief Depressions and Minor Depressions
Medical Differential Diagnosis and Evaluation
Medications Causing Depression
Laboratory Evaluation
Psychiatric Differential Diagnosis
Depression
Mourning
Demoralization
Adjustment Disorder with Depressed Mood
Premenstrual Syndrome
Dementia Syndromes
Mania
Psychopharmacological Treatment
Pharmacotherapy of Major Depression (Unipolar Depression)
First-Line Agents
Second-Line Agents
Monoamine Oxidase (MAO) Inhibitors
Electroconvulsive Treatment
Other Options
Mood Stabilizers
Stimulants
Light Therapy
Antianxiety Agents
Strategies Used in Treatment-Resistant Depressions
Continuation Treatment of Unipolar Depression
Maintenance Treatment of Unipolar Disorder
Pharmacotherapy of Bipolar Disorder
Treatment of Acute Manic Episodes
Continuation Treatment of Manic or Hypomanic Episodes
Bipolar Depression -- Acute and Continuation Treatment
Maintenance Treatment of Bipolar Disorder
4. Anxiety Disorders and Insomnia
Diagnosis
Natural History, Epidemiology, and Genetics
Medical Differential Diagnosis
Medical and Laboratory Evaluation
Psychiatric Differential Diagnosis
Psychopharmacological Treatment
Acute Treatment of Panic Disorder
Continuation and Maintenance Treatment for Panic Disorder
Social Phobia
Obsessive Compulsive Disorder
Post-traumatic Stress Disorder
Generalized Anxiety Disorder
Continuation and Maintenance
Treatment of Generalized Anxiety
Insomnia
Diagnosis
Treatment
5. Schizophrenia and Related Disorders
Diagnosis
Subtypes of Schizophrenia
Natural History, Epidemiology, and Genetics
Disorders Related to Schizophrenia
Schizophreniform Disorder
Schizoaffective Disorder
Delusional Disorder
Schizotypal Personality Disorder
Medical Differential Diagnosis
Laboratory Evaluation
Psychiatric Differential Diagnosis
Psychopharmacological Treatment
Psychopharmacological Treatment of Acute Schizophrenia
Alternative Treatments of Acute Schizophrenia
Acute Treatment of Schizoaffective Disorder
Continuation Treatment of Acute Schizophrenia
Maintenance Treatment of Schizophrenia
Maintenance Treatment of Schizoaffective Disorder
Treatment of Depression in Schizophrenia
6. Disorders of Impulse Control: Eating Disorders, Drug and Alcohol Abuse,
and Adult Attention Deficit/Hyperactivity Disorder (ADHD)
Eating Disorders
Anorexia Nervosa
Bulimia Nervosa
Adult Attention Deficit/Hyperactivity Disorder
Psychopharmacological Treatment
Alcohol and Drug Abuse
Alcohol Abuse
Cocaine Abuse
Opiate Abuse (Heroin and Narcotic Analgesics)
Other Drugs
7. Personality Disorders
Diagnosis
Subtypes
Cluster A: Odd or Eccentric Personality Disorders
Cluster B: Emotional or Chaotic Personality Disorders
Cluster C: Anxious or Fearful Personality Disorders
Natural History, Epidemiology, and Genetics
Psychopharmacological Treatment of Personality Disorders
Conceptual Models of Pharmacotherapy: What Are We Treating?
Psychopharmacological Treatment of Specific Personality Disorders
Cluster A: Odd or Eccentric Personality Types Cluster
B: Emotional or Chaotic Personality Types Cluster
C: Anxious or Fearful Types
Depressive Spectrum Personality Disorders
Management Issues
8. Treatment of Special Populations: Children/Adolescents, the Elderly, and
Women
Child and Adolescent Disorders
Mood Disorders
Diagnosis
Pharmacotherapy
Childhood Schizophrenia
Diagnosis
Pharmacotherapy
Pervasive Developmental Disorders: Autistic Disorder, Asperger's Syndrome,
and Related Entities
Diagnosis
Pharmacotherapy
Anxiety Disorders
Diagnosis
Pharmacotherapy
Attention Deficit/Hyperactivity Disorder
Diagnosis
Pharmacotherapy
Sleep Disorders
Diagnosis
Pharmacotherapy
Behavioral Conditions
Enuresis
Conduct Disorder
Aggressive, Destructive Behavior in Mentally Retarded Children
Tourette's Disorder
Diagnosis
Pharmacotherapy
Geriatric Disorders
Pharmacotherapy for Common Disorders
Mood Disorders
Psychotic Disorders
Anxiety Disorders and Insomnia
Medications Used in Treating Dementias
Female-Specific Issues and Disorders
Premenstrual Syndrome
Medications During Pregnancy
Antidepressants
Antianxiety Drugs
Mood Stabilizers
Antipsychotics
Electroconvulsive Treatment
Postpartum Period and Breastfeeding
Menopause
SECTION FOUR
9. Antidepressants
History
Classification
Cyclic Antidepressants
Clinical Uses
Biologic Effects
Choosing a Cyclic Antidepressant
Antidepressant Classes: Prescribing Techniques and Side Effects
General Principles
Selective Serotonin Reuptake Inhibitors (SSRIs)
Novel Antidepressants
Tricyclic Antidepressants (and Related Compounds)
Monoamine Oxidase (MAO) Inhibitors
Clinical Uses
Biologic Effects
Choice of Agents and Techniques for Prescribing
Food and Drug Interactions
Other Side Effects
10. Lithium and Other Mood Stabilizers
History
Lithium
Clinical Uses
Biologic Effects
Techniques for Prescribing
Side Effects
Lithium's Effects on Thyroid and Kidneys
Lithium Toxicity
Lithium Discontinuation
Anticonvulsant Mood Stabilizers
Carbamazepine
Clinical Uses
Biologic Effects
Techniques for Prescribing
Side Effects
Valproate
Clinical Uses
Biologic Effects
Techniques for Prescribing
Side Effects
11. Antianxiety Medications and Hypnotics
History
Benzodiazepines
Clinical Uses
Biologic Effects
Choosing a Benzodiazepine
Techniques for Prescribing
Benzodiazepine Withdrawal
Other Side Effects
Zolpidem Buspirone
Nonbarbiturate Sedatives and Hypnotics
Barbiturates
L-Tryptophan and Melatonin
Antihistamines
Clonidine
Beta-blockers
In the Future
12. Antipsychotics
History
Clinical Uses
Biologic Effects
Choosing an Antipsychotic
Atypical Antipsychotics
Techniques for Prescribing
Side Effects
Acute Side Effects
Dystonic Reactions
Akinesia
Akathisia
Neuroleptic
Malignant Syndrome
Non-Neurological Side Effects
Tardive Dyskinesia
Antiparkinsonian Medications
13. Electroconvulsive Therapy (ECT); Stimulants
ECT
Clinical Uses
Mechanisms of Action
Techniques of Administration
Side Effects
Stimulants
Clinical Uses
Mechanisms of Action
Techniques of Administration
Side Effects
SECTION FIVE
14. The Split Treatment Model: Interactions Between Psychotherapy and
Pharmacotherapy
Early Models, Early Problems
Psychotherapy/Pharmacotherapy Interactions: Theoretical Issues
Therapeutic Split Model
Advantages of the Split Model
Disadvantages of the Split Model
Psychodynamics of Psychopharmacology
Patient Education
Medication Compliance: Intra- and Interpersonal Factors
Technical Aspects of Split Treatment
Choosing a Psychopharmacologist
Finding a Psychopharmacologist in Your Community or Group
The Consultation Process
The Initial Consultation
Working in an Ongoing Split Treatment
Appendix: Psychiatric Medications
References
Index